32
Participants
Start Date
June 1, 2015
Primary Completion Date
February 8, 2018
Study Completion Date
February 8, 2018
Fitbit
Women enrolled in the study will be asked to wear a Fitbit from one week prior to chemotherapy until six months post-chemotherapy. The Fitbit is a watch-sized, wrist worn, physical activity tracker. A button, when pressed, displays the wearer's accumulated daily steps, mileage, and steps climbed.
University of California, San Diego, La Jolla
National Cancer Institute (NCI)
NIH
University of California, San Diego
OTHER